{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T08:48:10Z","timestamp":1764060490330},"reference-count":39,"publisher":"Tohoku University Medical Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2011]]},"DOI":"10.1620\/tjem.224.151","type":"journal-article","created":{"date-parts":[[2011,5,30]],"date-time":"2011-05-30T06:07:40Z","timestamp":1306735660000},"page":"151-160","source":"Crossref","is-referenced-by-count":17,"title":["Clinicopathological Features of Malignant Lymphoma in Japan: The Miyagi Study"],"prefix":"10.1620","volume":"224","author":[{"given":"Yukiko","family":"Miura","sequence":"first","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Fukuhara","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joji","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsura","family":"Kohata","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Ishizawa","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Ichinohasama","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Harigae","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008265532487"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2007.02207.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Belaud-Rotureau, M.A., Parrens, M., Carrere, N., Turmo, M., Ferrer, J., de Mascarel, A., Dubus, P. &amp; Merlio, J.P. (2007) Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma. <i>Hum. Pathol<\/i>., <b>38<\/b>, 365-372.","DOI":"10.1016\/j.humpath.2006.08.022"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Biagi, J.J. &amp; Seymour, J.F. (2002) Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation. <i>Blood<\/i>, <b>99<\/b>, 4265-4275.","DOI":"10.1182\/blood.V99.12.4265"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Chuang, S.S., Lin, C.N. &amp; Li, C.Y. (2000) Malignant lymphoma in southern Taiwan according to the revised European-American classification of lymphoid neoplasms. <i>Cancer<\/i>, <b>89<\/b>, 1586-1592.","DOI":"10.1002\/1097-0142(20001001)89:7<1586::AID-CNCR24>3.0.CO;2-1"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011795"},{"key":"7","doi-asserted-by":"crossref","unstructured":"D'Haese, J.G., Tsukasaki, K., Cremer, F.W., Fischer, C., Bartram, C.R. &amp; Jauch, A. (2005) Chromosomal aberrations in follicular non-Hodgkin lymphomas of Japanese patients, detected with comparative genomic hybridization and polymerase chain reaction analysis. <i>Cancer Genet. Cytogenet<\/i>., <b>162<\/b>, 107-114.","DOI":"10.1016\/j.cancergencyto.2005.04.004"},{"key":"8","unstructured":"Dorfman, D.M. &amp; Shahsafaei, A. (1997) Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in paraffin sections. <i>Mod. Pathol<\/i>., <b>10<\/b>, 859-863."},{"key":"9","doi-asserted-by":"crossref","unstructured":"Einerson, R.R., Kurtin, P.J., Dayharsh, G.A., Kimlinger, T.K. &amp; Remstein, E.D. (2005) FISH is superior to PCR in detecting t(14;18)(q32;q21)-IgH\/bcl-2 in follicular lymphoma using paraffin-embedded tissue samples. <i>Am. J. Clin. Pathol<\/i>., <b>124<\/b>, 421-429.","DOI":"10.1309\/BLH8MMK85UBQ4K6R"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn392"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.09.131"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.1674"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Godon, A., Moreau, A., Talmant, P., Baranger-Papot, L., Genevi&egrave;ve, F., Milpied, N., Zandecki, M. &amp; Avet-Loiseau, H. (2003) Is t(14;18)(q32;q21) a constant finding in follicular lymphoma? An interphase FISH study on 63 patients. <i>Leukemia<\/i>, <b>17<\/b>, 255-259.","DOI":"10.1038\/sj.leu.2402739"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Guo, Y., Karube, K., Kawano, R., Yamaguchi, T., Suzumiya, J., Huang, G.S. &amp; Ohshima, K. (2005) Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances. <i>Leukemia<\/i>, <b>19<\/b>, 1058-1063.","DOI":"10.1038\/sj.leu.2403738"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1545"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(94)00193-6"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Hiraga, J., Tomita, A., Sugimoto, T., Shimada, K., Ito, M., Nakamura, S., Kiyoi, H., Kinoshita, T. &amp; Naoe, T. (2009) Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance. <i>Blood<\/i>, <b>113<\/b>, 4885-4893.","DOI":"10.1182\/blood-2008-08-175208"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Horsman, D.E., Gascoyne, R.D., Coupland, R.W., Coldman, A.J. &amp; Adomat, S.A. (1995) Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14; 18) in follicular lymphoma. <i>Am. J. Clin. Pathol<\/i>., <b>103<\/b>, 472-478.","DOI":"10.1093\/ajcp\/103.4.472"},{"key":"19","unstructured":"Jaffe, E.S., Harris, N.L., Stein, H. &amp; Vardiman, J.W. (2001) <i>Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues<\/i>, International Agency for Research on Cancer, Lyon."},{"key":"20","doi-asserted-by":"crossref","unstructured":"Johnson, N.A., Leach, S., Woolcock, B., deLeeuw, R.J., Bashashati, A., Sehn, L.H., Connors, J.M., Chhanabhai, M., Brooks-Wilson, A. &amp; Gascoyne, R.D. (2009) CD20 mutations involving the rituximab epitope are rare in diffuse large B-cell lymphomas and are not a significant causes of R-CHOP failure. <i>Haematologica<\/i>, <b>94<\/b>, 423-427.","DOI":"10.3324\/haematol.2008.001024"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Karube, K., Guo, Y., Suzumiya, J., Sugita, Y., Nomura, Y., Yamamoto, K., Shimizu, K., Yoshida, S., Komatani, H., Takeshita, M., Kikuchi, M., Nakamura, N., Takasu, O., Arakawa, F., Tagawa, H., Seto, M. &amp; Ohshima, K. (2007) CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features. <i>Blood<\/i>, <b>109<\/b>, 3076-3079.","DOI":"10.1182\/blood-2006-09-045989"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Karube, K., Ying, G., Tagawa, H., Niino, D., Aoki, R., Kimura, Y., Hashikawa, K., Suefuji, N., Sugita, Y., Nomura, Y., Shimizu, K., Yoshida, S., Seto, M. &amp; Ohshima, K. (2008) BCL6 gene amplification\/3q27 gain is associated with unique clinicopathological characteristics among follicular lymphoma without BCL2 gene translocation. <i>Mod. Pathol<\/i>., <b>21<\/b>, 973-978.","DOI":"10.1038\/modpathol.2008.75"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Katzenberger, T., Ott, G., Klein, T., Kalla, J., M&uuml;ller-Hermelink, H.K. &amp; Ott, M.M. (2004) Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component. <i>Am. J. Pathol<\/i>., <b>165<\/b>, 481-490.","DOI":"10.1016\/S0002-9440(10)63313-5"},{"key":"24","unstructured":"Ko, Y.H., Kim, C.W., Park, C.S., Jang, H.K., Lee, S.S., Kim, S.H., Ree, H.J., Lee, J.D., Kim, S.W. &amp; Huh, J.R. (1998) REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. <i>Cancer<\/i>, <b>83<\/b>, 806-812."},{"key":"25","doi-asserted-by":"crossref","unstructured":"Lee, M.Y., Tan, T.D., Feng, A.C. &amp; Liu, M.C. (2006) Clinicopathological analysis of 598 malignant lymphomas in Taiwan: seven-year experience in a single institution. <i>Am. J. Hematol<\/i>., <b>81<\/b>, 568-575.","DOI":"10.1002\/ajh.20649"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-198580"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1827.2000.01108.x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Matsumoto, Y., Nomura, K., Matsumoto, S., Ueda, K., Nakao, M., Nishida, K., Sakabe, H., Yokota, S., Horiike, S., Nakamine, H., Nakamura, S. &amp; Taniwaki, M. (2004) Detection of t(14;18) in follicular lymphoma by dual-color fluorescence in situ hybridization on paraffin-embedded tissue sections. <i>Cancer Genet. Cytogenet<\/i>., <b>150<\/b>, 22-26.","DOI":"10.1016\/j.cancergencyto.2003.08.008"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Miyazato, H., Nakatsuka, S., Miyanaga, I., Hanamoto, H., Tatsumi, Y., Matsuda, M., Maeda, Y., Kanamaru, A. &amp; Aozasa, K.; Group, O.L.S. (2002) Follicular lymphoma in Osaka, Japan: histological features and chronological change. <i>Int. J. Hematol<\/i>., <b>76<\/b>, 333-337.","DOI":"10.1007\/BF02982692"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Morton, L.M., Wang, S.S., Devesa, S.S., Hartge, P., Weisenburger, D.D. &amp; Linet, M.S. (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. <i>Blood<\/i>, <b>107<\/b>, 265-276.","DOI":"10.1182\/blood-2005-06-2508"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Ott, G., Katzenberger, T., Lohr, A., Kindelberger, S., R&uuml;diger, T., Wilhelm, M., Kalla, J., Rosenwald, A., M&uuml;ller, J.G., Ott, M.M. &amp; M&uuml;ller-Hermelink, H.K. (2002) Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. <i>Blood<\/i>, <b>99<\/b>, 3806-3812.","DOI":"10.1182\/blood.V99.10.3806"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Pezzella, F., Ralfkiaer, E., Gatter, K.C. &amp; Mason, D.Y. (1990) The 14;18 translocation in European cases of follicular lymphoma: comparison of Southern blotting and the polymerase chain reaction. <i>Br. J. Haematol<\/i>., <b>76<\/b>, 58-64.","DOI":"10.1111\/j.1365-2141.1990.tb07836.x"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2009.09.059"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Sukpanichnant, S. (2004) Analysis of 1983 cases of malignant lymphoma in Thailand according to the World Health Organization classification. <i>Hum. Pathol<\/i>., <b>35<\/b>, 224-230.","DOI":"10.1016\/j.humpath.2003.10.007"},{"key":"35","unstructured":"Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri. S.A., Stein, H., Thiele, J. &amp; Vardiman, J.W. (2008) <i>WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues<\/i>, 4th ed., International Agency for Research on Cancer, Lyon."},{"key":"36","doi-asserted-by":"crossref","unstructured":"Taniguchi, M., Oka, K., Hiasa, A., Yamaguchi, M., Ohno, T., Kita, K. &amp; Shiku, H. (1998) De novo CD5+ diffuse large B-cell lymphomas express VH genes with somatic mutation. <i>Blood<\/i>, <b>91<\/b>, 1145-1151.","DOI":"10.1182\/blood.V91.4.1145"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1403"},{"key":"38","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.3.815"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Yunis, J.J., Oken, M.M., Kaplan, M.E., Ensrud, K.M., Howe, R.R. &amp; Theologides, A. (1982) Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. <i>N. Engl. J. Med<\/i>., <b>307<\/b>, 1231-1236.","DOI":"10.1056\/NEJM198211113072002"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/tjem\/224\/2\/224_2_151\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T19:41:04Z","timestamp":1619638864000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/tjem\/224\/2\/224_2_151\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.224.151","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}